

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.81179539 |
| 2 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.58200293 |
| 3 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.56798725 |
| 4 | sarcomere organization (GO:0045214) | 4.42459642 |
| 5 | plasma membrane repair (GO:0001778) | 4.35103580 |
| 6 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.35047992 |
| 7 | cardiac myofibril assembly (GO:0055003) | 4.30537882 |
| 8 | carnitine shuttle (GO:0006853) | 4.19739476 |
| 9 | skeletal muscle contraction (GO:0003009) | 4.19317544 |
| 10 | cell communication involved in cardiac conduction (GO:0086065) | 4.17270195 |
| 11 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.17088202 |
| 12 | cell communication by electrical coupling (GO:0010644) | 4.09906809 |
| 13 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.98291497 |
| 14 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.93808083 |
| 15 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.93504288 |
| 16 | axonemal dynein complex assembly (GO:0070286) | 3.91400617 |
| 17 | cardiac muscle contraction (GO:0060048) | 3.89631206 |
| 18 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.86546047 |
| 19 | actin filament-based movement (GO:0030048) | 3.83692372 |
| 20 | fatty acid transmembrane transport (GO:1902001) | 3.80332163 |
| 21 | myofibril assembly (GO:0030239) | 3.79964081 |
| 22 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.55071123 |
| 23 | sodium ion export (GO:0071436) | 3.54403032 |
| 24 | regulation of membrane repolarization (GO:0060306) | 3.52357036 |
| 25 | tricarboxylic acid cycle (GO:0006099) | 3.50620349 |
| 26 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.42106057 |
| 27 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.31021721 |
| 28 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.30175207 |
| 29 | regulation of actin filament-based movement (GO:1903115) | 3.28756348 |
| 30 | response to inactivity (GO:0014854) | 3.26523755 |
| 31 | muscle filament sliding (GO:0030049) | 3.17989860 |
| 32 | actin-myosin filament sliding (GO:0033275) | 3.17989860 |
| 33 | carnitine transmembrane transport (GO:1902603) | 3.14629525 |
| 34 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.14588503 |
| 35 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.14149849 |
| 36 | actomyosin structure organization (GO:0031032) | 3.12231019 |
| 37 | potassium ion import (GO:0010107) | 3.12143802 |
| 38 | striated muscle contraction (GO:0006941) | 3.11826412 |
| 39 | regulation of skeletal muscle contraction (GO:0014819) | 3.08924350 |
| 40 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.08690226 |
| 41 | 2-oxoglutarate metabolic process (GO:0006103) | 3.08660279 |
| 42 | cardiac muscle hypertrophy (GO:0003300) | 3.05947166 |
| 43 | cardiac conduction (GO:0061337) | 3.05628143 |
| 44 | regulation of synapse structural plasticity (GO:0051823) | 3.02986123 |
| 45 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.02179916 |
| 46 | locomotory exploration behavior (GO:0035641) | 2.98650262 |
| 47 | motile cilium assembly (GO:0044458) | 2.98177898 |
| 48 | carnitine transport (GO:0015879) | 2.95347304 |
| 49 | amino-acid betaine transport (GO:0015838) | 2.95347304 |
| 50 | striated muscle hypertrophy (GO:0014897) | 2.95057879 |
| 51 | activation of protein kinase A activity (GO:0034199) | 2.95040470 |
| 52 | regulation of fatty acid oxidation (GO:0046320) | 2.94658278 |
| 53 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.94519363 |
| 54 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.91157866 |
| 55 | relaxation of cardiac muscle (GO:0055119) | 2.91121672 |
| 56 | lysine metabolic process (GO:0006553) | 2.90330236 |
| 57 | lysine catabolic process (GO:0006554) | 2.90330236 |
| 58 | cardiac muscle cell development (GO:0055013) | 2.90286117 |
| 59 | regulation of cell communication by electrical coupling (GO:0010649) | 2.90261878 |
| 60 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.89984195 |
| 61 | creatine metabolic process (GO:0006600) | 2.89852261 |
| 62 | regulation of the force of heart contraction (GO:0002026) | 2.89254737 |
| 63 | cardiac muscle cell action potential (GO:0086001) | 2.87605980 |
| 64 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.86739261 |
| 65 | cellular potassium ion homeostasis (GO:0030007) | 2.86695887 |
| 66 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.86181784 |
| 67 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.86181784 |
| 68 | striated muscle adaptation (GO:0014888) | 2.85427586 |
| 69 | cilium movement (GO:0003341) | 2.84949099 |
| 70 | negative regulation of potassium ion transport (GO:0043267) | 2.76841940 |
| 71 | muscle contraction (GO:0006936) | 2.76599819 |
| 72 | heart trabecula formation (GO:0060347) | 2.76239422 |
| 73 | synaptic vesicle maturation (GO:0016188) | 2.75862337 |
| 74 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.75638170 |
| 75 | response to muscle activity (GO:0014850) | 2.74833510 |
| 76 | cardiac cell development (GO:0055006) | 2.74569866 |
| 77 | NADH metabolic process (GO:0006734) | 2.72906960 |
| 78 | regulation of striated muscle contraction (GO:0006942) | 2.72346174 |
| 79 | membrane repolarization (GO:0086009) | 2.72108138 |
| 80 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.71188568 |
| 81 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.71044359 |
| 82 | vocalization behavior (GO:0071625) | 2.70316017 |
| 83 | membrane repolarization during action potential (GO:0086011) | 2.70313424 |
| 84 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.68921392 |
| 85 | adult heart development (GO:0007512) | 2.68300262 |
| 86 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.67779747 |
| 87 | positive regulation of cation channel activity (GO:2001259) | 2.66813572 |
| 88 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.65287021 |
| 89 | actin-mediated cell contraction (GO:0070252) | 2.64157107 |
| 90 | negative regulation of cell size (GO:0045792) | 2.62737206 |
| 91 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.62036004 |
| 92 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.61510455 |
| 93 | cardiac muscle adaptation (GO:0014887) | 2.60768719 |
| 94 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.60768719 |
| 95 | muscle hypertrophy in response to stress (GO:0003299) | 2.60768719 |
| 96 | regulation of sequestering of triglyceride (GO:0010889) | 2.60015176 |
| 97 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.59464672 |
| 98 | positive regulation of sodium ion transport (GO:0010765) | 2.59218045 |
| 99 | regulation of relaxation of muscle (GO:1901077) | 2.59131237 |
| 100 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.58417246 |
| 101 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.57967482 |
| 102 | aspartate family amino acid catabolic process (GO:0009068) | 2.56873377 |
| 103 | positive regulation of fatty acid oxidation (GO:0046321) | 2.56783325 |
| 104 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.56440914 |
| 105 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.53325567 |
| 106 | cellular sodium ion homeostasis (GO:0006883) | 2.53023705 |
| 107 | layer formation in cerebral cortex (GO:0021819) | 2.51645255 |
| 108 | skeletal muscle adaptation (GO:0043501) | 2.51548589 |
| 109 | muscle hypertrophy (GO:0014896) | 2.51348459 |
| 110 | regulation of ARF protein signal transduction (GO:0032012) | 2.51254743 |
| 111 | regulation of heart rate (GO:0002027) | 2.50849633 |
| 112 | muscle system process (GO:0003012) | 2.49483623 |
| 113 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.48648305 |
| 114 | regulation of p38MAPK cascade (GO:1900744) | 2.47197940 |
| 115 | regulation of coenzyme metabolic process (GO:0051196) | 2.44561088 |
| 116 | regulation of cofactor metabolic process (GO:0051193) | 2.44561088 |
| 117 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.43811603 |
| 118 | regulation of heart contraction (GO:0008016) | 2.43402388 |
| 119 | camera-type eye morphogenesis (GO:0048593) | 2.42752495 |
| 120 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.41676655 |
| 121 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.40654006 |
| 122 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.40052074 |
| 123 | skeletal muscle fiber development (GO:0048741) | 2.38943384 |
| 124 | cellular response to catecholamine stimulus (GO:0071870) | 2.38771580 |
| 125 | cellular response to monoamine stimulus (GO:0071868) | 2.38771580 |
| 126 | cell-cell junction maintenance (GO:0045217) | 2.38416193 |
| 127 | cell junction maintenance (GO:0034331) | 2.33179087 |
| 128 | myoblast fusion (GO:0007520) | 2.29829253 |
| 129 | cerebellar granule cell differentiation (GO:0021707) | 2.29669571 |
| 130 | muscle tissue morphogenesis (GO:0060415) | 2.28615619 |
| 131 | nucleus localization (GO:0051647) | 2.28167876 |
| 132 | myotube differentiation (GO:0014902) | 2.26696079 |
| 133 | establishment of nucleus localization (GO:0040023) | 2.23900493 |
| 134 | cellular response to epinephrine stimulus (GO:0071872) | 2.22651164 |
| 135 | negative regulation of inclusion body assembly (GO:0090084) | 2.19882164 |
| 136 | response to monoamine (GO:0071867) | 2.19521742 |
| 137 | response to catecholamine (GO:0071869) | 2.19521742 |
| 138 | left/right pattern formation (GO:0060972) | 2.18447782 |
| 139 | muscle adaptation (GO:0043500) | 2.16182022 |
| 140 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.15788418 |
| 141 | positive regulation of myotube differentiation (GO:0010831) | 2.12444706 |
| 142 | epithelial cell-cell adhesion (GO:0090136) | 2.12388056 |
| 143 | negative regulation of protein localization to cell surface (GO:2000009) | 2.11766844 |
| 144 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.11267294 |
| 145 | glycogen catabolic process (GO:0005980) | 2.11210855 |
| 146 | skeletal muscle tissue development (GO:0007519) | 2.10921034 |
| 147 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.10247906 |
| 148 | macroautophagy (GO:0016236) | 2.10030924 |
| 149 | cell-substrate adherens junction assembly (GO:0007045) | 2.09210070 |
| 150 | focal adhesion assembly (GO:0048041) | 2.09210070 |
| 151 | interkinetic nuclear migration (GO:0022027) | 2.09053001 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.07661331 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.04916773 |
| 3 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.34009144 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.23646287 |
| 5 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.99919449 |
| 6 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.98028597 |
| 7 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.97259830 |
| 8 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.90570212 |
| 9 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.86458644 |
| 10 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.83630386 |
| 11 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.83126133 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.82385259 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.77827946 |
| 14 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.73926018 |
| 15 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.73926018 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73459302 |
| 17 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.73036814 |
| 18 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.72915263 |
| 19 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.70712254 |
| 20 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.68557730 |
| 21 | KDM2B_26808549_Chip-Seq_K562_Human | 1.66232215 |
| 22 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.63340986 |
| 23 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.62749343 |
| 24 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.62749343 |
| 25 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.60169984 |
| 26 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.56679616 |
| 27 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.55764242 |
| 28 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.52588364 |
| 29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.52478506 |
| 30 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.51830689 |
| 31 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.44021389 |
| 32 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.42141877 |
| 33 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.41458673 |
| 34 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.41406945 |
| 35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.40452593 |
| 36 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.40338912 |
| 37 | * ZNF263_19887448_ChIP-Seq_K562_Human | 1.39436007 |
| 38 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.39022961 |
| 39 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.37745021 |
| 40 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37621117 |
| 41 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.35074108 |
| 42 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.33428997 |
| 43 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.33365098 |
| 44 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.32745608 |
| 45 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.31775514 |
| 46 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.30782102 |
| 47 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.30273057 |
| 48 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.29557550 |
| 49 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.27873932 |
| 50 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.27746699 |
| 51 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.26824799 |
| 52 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25983039 |
| 53 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.25245029 |
| 54 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.24631259 |
| 55 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.22535568 |
| 56 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.21832255 |
| 57 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20282243 |
| 58 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.20172011 |
| 59 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.20061249 |
| 60 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.19870094 |
| 61 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.17843553 |
| 62 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.15794238 |
| 63 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.15062743 |
| 64 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.15028763 |
| 65 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.13864649 |
| 66 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.13180877 |
| 67 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.12736131 |
| 68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.12230841 |
| 69 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.10961467 |
| 70 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.10018634 |
| 71 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.10008632 |
| 72 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.09418187 |
| 73 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09253071 |
| 74 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.08977332 |
| 75 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.07794519 |
| 76 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.07558520 |
| 77 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.06288911 |
| 78 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.05812975 |
| 79 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05193379 |
| 80 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.04978356 |
| 81 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.04763153 |
| 82 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.03934421 |
| 83 | AR_19668381_ChIP-Seq_PC3_Human | 1.01108639 |
| 84 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00931177 |
| 85 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.00300315 |
| 86 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.99803680 |
| 87 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.99667056 |
| 88 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99640237 |
| 89 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99225199 |
| 90 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99055103 |
| 91 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.98037500 |
| 92 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97837615 |
| 93 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.97354487 |
| 94 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95608793 |
| 95 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94781506 |
| 96 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.94692736 |
| 97 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.94267803 |
| 98 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94201437 |
| 99 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.94000405 |
| 100 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.93863186 |
| 101 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.93831334 |
| 102 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.93508604 |
| 103 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.93434647 |
| 104 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.91857795 |
| 105 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90985720 |
| 106 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90025420 |
| 107 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.90017275 |
| 108 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.88817569 |
| 109 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.88759915 |
| 110 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.88474911 |
| 111 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.87921191 |
| 112 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.87243806 |
| 113 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.86547688 |
| 114 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85920501 |
| 115 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.85887073 |
| 116 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.84764030 |
| 117 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.84606653 |
| 118 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84444931 |
| 119 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84440263 |
| 120 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.84196951 |
| 121 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.84016715 |
| 122 | * PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.80990474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.19731163 |
| 2 | MP0000751_myopathy | 4.24729339 |
| 3 | MP0003646_muscle_fatigue | 4.21377891 |
| 4 | MP0004084_abnormal_cardiac_muscle | 3.66094412 |
| 5 | MP0004215_abnormal_myocardial_fiber | 3.36457312 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 3.05631346 |
| 7 | MP0004036_abnormal_muscle_relaxation | 3.01936261 |
| 8 | MP0004130_abnormal_muscle_cell | 2.98713716 |
| 9 | MP0005409_darkened_coat_color | 2.78383069 |
| 10 | MP0005330_cardiomyopathy | 2.67230446 |
| 11 | MP0000749_muscle_degeneration | 2.53849777 |
| 12 | MP0004087_abnormal_muscle_fiber | 2.45376514 |
| 13 | MP0002972_abnormal_cardiac_muscle | 2.18738044 |
| 14 | MP0005620_abnormal_muscle_contractility | 2.10280646 |
| 15 | MP0003137_abnormal_impulse_conducting | 2.02142022 |
| 16 | MP0004145_abnormal_muscle_electrophysio | 1.97599622 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 1.94954774 |
| 18 | MP0004484_altered_response_of | 1.94656505 |
| 19 | MP0008775_abnormal_heart_ventricle | 1.93881455 |
| 20 | MP0002269_muscular_atrophy | 1.91954102 |
| 21 | MP0002909_abnormal_adrenal_gland | 1.91526847 |
| 22 | MP0005670_abnormal_white_adipose | 1.90503430 |
| 23 | MP0000733_abnormal_muscle_development | 1.86922525 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 1.85536884 |
| 25 | MP0010630_abnormal_cardiac_muscle | 1.85515857 |
| 26 | MP0008961_abnormal_basal_metabolism | 1.83980579 |
| 27 | MP0005666_abnormal_adipose_tissue | 1.83965825 |
| 28 | MP0000747_muscle_weakness | 1.81636517 |
| 29 | MP0002822_catalepsy | 1.79015350 |
| 30 | MP0000750_abnormal_muscle_regeneration | 1.77462956 |
| 31 | MP0006138_congestive_heart_failure | 1.77051183 |
| 32 | MP0001544_abnormal_cardiovascular_syste | 1.76218830 |
| 33 | MP0005385_cardiovascular_system_phenoty | 1.76218830 |
| 34 | MP0004085_abnormal_heartbeat | 1.72756352 |
| 35 | * MP0002106_abnormal_muscle_physiology | 1.71898542 |
| 36 | MP0005451_abnormal_body_composition | 1.67949344 |
| 37 | MP0005360_urolithiasis | 1.66283894 |
| 38 | MP0004233_abnormal_muscle_weight | 1.63074448 |
| 39 | MP0004270_analgesia | 1.61325554 |
| 40 | MP0000759_abnormal_skeletal_muscle | 1.56243113 |
| 41 | MP0004510_myositis | 1.55393360 |
| 42 | MP0003635_abnormal_synaptic_transmissio | 1.53836291 |
| 43 | MP0004185_abnormal_adipocyte_glucose | 1.49794507 |
| 44 | MP0005085_abnormal_gallbladder_physiolo | 1.44385809 |
| 45 | MP0009384_cardiac_valve_regurgitation | 1.43721409 |
| 46 | MP0005423_abnormal_somatic_nervous | 1.43196936 |
| 47 | MP0004858_abnormal_nervous_system | 1.42325444 |
| 48 | MP0005375_adipose_tissue_phenotype | 1.41034236 |
| 49 | MP0002139_abnormal_hepatobiliary_system | 1.40563755 |
| 50 | MP0000566_synostosis | 1.37488616 |
| 51 | * MP0005369_muscle_phenotype | 1.37482075 |
| 52 | MP0003252_abnormal_bile_duct | 1.24174029 |
| 53 | MP0003091_abnormal_cell_migration | 1.21531945 |
| 54 | MP0010234_abnormal_vibrissa_follicle | 1.21008660 |
| 55 | MP0010329_abnormal_lipoprotein_level | 1.20293900 |
| 56 | MP0005503_abnormal_tendon_morphology | 1.19841275 |
| 57 | MP0005365_abnormal_bile_salt | 1.19754563 |
| 58 | MP0003045_fibrosis | 1.16014137 |
| 59 | MP0003329_amyloid_beta_deposits | 1.15476103 |
| 60 | MP0002234_abnormal_pharynx_morphology | 1.14232128 |
| 61 | MP0002063_abnormal_learning/memory/cond | 1.12592604 |
| 62 | MP0005167_abnormal_blood-brain_barrier | 1.12583314 |
| 63 | MP0001958_emphysema | 1.12335561 |
| 64 | MP0003123_paternal_imprinting | 1.11855293 |
| 65 | MP0001299_abnormal_eye_distance/ | 1.11019252 |
| 66 | MP0002896_abnormal_bone_mineralization | 1.10797392 |
| 67 | MP0003279_aneurysm | 1.08315643 |
| 68 | MP0008569_lethality_at_weaning | 1.07289897 |
| 69 | MP0003828_pulmonary_edema | 1.07006974 |
| 70 | MP0000003_abnormal_adipose_tissue | 1.04338796 |
| 71 | MP0002249_abnormal_larynx_morphology | 1.04105983 |
| 72 | MP0000534_abnormal_ureter_morphology | 1.01186306 |
| 73 | MP0003221_abnormal_cardiomyocyte_apopto | 0.99973552 |
| 74 | MP0009745_abnormal_behavioral_response | 0.99010750 |
| 75 | MP0001984_abnormal_olfaction | 0.98239849 |
| 76 | MP0002971_abnormal_brown_adipose | 0.98066928 |
| 77 | MP0005535_abnormal_body_temperature | 0.97792078 |
| 78 | MP0003122_maternal_imprinting | 0.97265627 |
| 79 | MP0002118_abnormal_lipid_homeostasis | 0.96982385 |
| 80 | MP0000013_abnormal_adipose_tissue | 0.96915885 |
| 81 | MP0005257_abnormal_intraocular_pressure | 0.96209333 |
| 82 | MP0005275_abnormal_skin_tensile | 0.92904298 |
| 83 | MP0003879_abnormal_hair_cell | 0.91484408 |
| 84 | MP0009046_muscle_twitch | 0.91158282 |
| 85 | MP0002064_seizures | 0.90206278 |
| 86 | MP0004043_abnormal_pH_regulation | 0.89338536 |
| 87 | MP0002078_abnormal_glucose_homeostasis | 0.89192572 |
| 88 | MP0005187_abnormal_penis_morphology | 0.85891719 |
| 89 | MP0003950_abnormal_plasma_membrane | 0.84905686 |
| 90 | MP0002332_abnormal_exercise_endurance | 0.84821022 |
| 91 | MP0000762_abnormal_tongue_morphology | 0.84636251 |
| 92 | MP0009840_abnormal_foam_cell | 0.83569292 |
| 93 | MP0003300_gastrointestinal_ulcer | 0.83527443 |
| 94 | MP0002127_abnormal_cardiovascular_syste | 0.83398351 |
| 95 | MP0001501_abnormal_sleep_pattern | 0.81734751 |
| 96 | MP0001440_abnormal_grooming_behavior | 0.81598523 |
| 97 | MP0008874_decreased_physiological_sensi | 0.80584151 |
| 98 | MP0006036_abnormal_mitochondrial_physio | 0.79427427 |
| 99 | MP0002653_abnormal_ependyma_morphology | 0.79227401 |
| 100 | MP0010368_abnormal_lymphatic_system | 0.78688834 |
| 101 | MP0000266_abnormal_heart_morphology | 0.78328792 |
| 102 | MP0002572_abnormal_emotion/affect_behav | 0.77166567 |
| 103 | MP0000230_abnormal_systemic_arterial | 0.76449335 |
| 104 | MP0008875_abnormal_xenobiotic_pharmacok | 0.76203808 |
| 105 | MP0004924_abnormal_behavior | 0.75901554 |
| 106 | MP0005386_behavior/neurological_phenoty | 0.75901554 |
| 107 | MP0003633_abnormal_nervous_system | 0.74853084 |
| 108 | MP0000778_abnormal_nervous_system | 0.74664592 |
| 109 | MP0005623_abnormal_meninges_morphology | 0.74587919 |
| 110 | MP0000767_abnormal_smooth_muscle | 0.73826185 |
| 111 | MP0001502_abnormal_circadian_rhythm | 0.71582555 |
| 112 | MP0001849_ear_inflammation | 0.71416618 |
| 113 | MP0003566_abnormal_cell_adhesion | 0.71385747 |
| 114 | MP0003075_altered_response_to | 0.71118238 |
| 115 | MP0000569_abnormal_digit_pigmentation | 0.70853443 |
| 116 | MP0001666_abnormal_nutrient_absorption | 0.69564507 |
| 117 | MP0003634_abnormal_glial_cell | 0.69534499 |
| 118 | MP0005165_increased_susceptibility_to | 0.69259280 |
| 119 | MP0002108_abnormal_muscle_morphology | 0.68915478 |
| 120 | MP0001486_abnormal_startle_reflex | 0.68723136 |
| 121 | MP0002272_abnormal_nervous_system | 0.68132041 |
| 122 | MP0005083_abnormal_biliary_tract | 0.67669741 |
| 123 | MP0005334_abnormal_fat_pad | 0.67226493 |
| 124 | MP0008438_abnormal_cutaneous_collagen | 0.66326547 |
| 125 | MP0005448_abnormal_energy_balance | 0.65443427 |
| 126 | MP0004134_abnormal_chest_morphology | 0.64761643 |
| 127 | MP0005319_abnormal_enzyme/_coenzyme | 0.64451798 |
| 128 | MP0002128_abnormal_blood_circulation | 0.63782241 |
| 129 | MP0003283_abnormal_digestive_organ | 0.62975834 |
| 130 | MP0000955_abnormal_spinal_cord | 0.62698673 |
| 131 | MP0002734_abnormal_mechanical_nocicepti | 0.61708163 |
| 132 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.61593544 |
| 133 | MP0001879_abnormal_lymphatic_vessel | 0.58226898 |
| 134 | MP0000678_abnormal_parathyroid_gland | 0.57745701 |
| 135 | MP0002168_other_aberrant_phenotype | 0.56500718 |
| 136 | MP0005076_abnormal_cell_differentiation | 0.56272613 |
| 137 | MP0009115_abnormal_fat_cell | 0.53790080 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 5.95037432 |
| 2 | Nemaline bodies (HP:0003798) | 5.60461217 |
| 3 | Exercise-induced myalgia (HP:0003738) | 5.03308924 |
| 4 | Bundle branch block (HP:0011710) | 4.52173823 |
| 5 | Ventricular tachycardia (HP:0004756) | 4.51424925 |
| 6 | Right ventricular cardiomyopathy (HP:0011663) | 4.34228817 |
| 7 | Exercise-induced muscle cramps (HP:0003710) | 4.29048943 |
| 8 | Hyporeflexia of lower limbs (HP:0002600) | 4.27170338 |
| 9 | Calf muscle hypertrophy (HP:0008981) | 4.20216640 |
| 10 | Atrial fibrillation (HP:0005110) | 4.11661039 |
| 11 | Syncope (HP:0001279) | 4.02701883 |
| 12 | Myoglobinuria (HP:0002913) | 3.95922851 |
| 13 | Primary atrial arrhythmia (HP:0001692) | 3.91289397 |
| 14 | Ventricular fibrillation (HP:0001663) | 3.91188931 |
| 15 | Muscle fiber splitting (HP:0003555) | 3.88038356 |
| 16 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.83853740 |
| 17 | Difficulty running (HP:0009046) | 3.72827072 |
| 18 | Supraventricular tachycardia (HP:0004755) | 3.68717413 |
| 19 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.67456534 |
| 20 | Abnormality of the calf musculature (HP:0001430) | 3.64286631 |
| 21 | Supraventricular arrhythmia (HP:0005115) | 3.63708895 |
| 22 | Prolonged QT interval (HP:0001657) | 3.62484833 |
| 23 | Distal arthrogryposis (HP:0005684) | 3.57710311 |
| 24 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.51478225 |
| 25 | Ventricular arrhythmia (HP:0004308) | 3.42966012 |
| 26 | Subaortic stenosis (HP:0001682) | 3.42560454 |
| 27 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.42560454 |
| 28 | Ulnar deviation of the wrist (HP:0003049) | 3.41139694 |
| 29 | Heart block (HP:0012722) | 3.37799008 |
| 30 | Myopathic facies (HP:0002058) | 3.37641132 |
| 31 | Round ear (HP:0100830) | 3.34750853 |
| 32 | Increased connective tissue (HP:0009025) | 3.33995853 |
| 33 | Dysmetric saccades (HP:0000641) | 3.32789388 |
| 34 | Abnormal ciliary motility (HP:0012262) | 3.30327323 |
| 35 | Asymmetric septal hypertrophy (HP:0001670) | 3.29193259 |
| 36 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.25539703 |
| 37 | Atrioventricular block (HP:0001678) | 3.24296303 |
| 38 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.20961243 |
| 39 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.20961243 |
| 40 | Lipoatrophy (HP:0100578) | 3.18570025 |
| 41 | Abnormal atrioventricular conduction (HP:0005150) | 3.15694761 |
| 42 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.09947454 |
| 43 | Absent/shortened dynein arms (HP:0200106) | 3.09947454 |
| 44 | EMG: myopathic abnormalities (HP:0003458) | 3.04043630 |
| 45 | Myotonia (HP:0002486) | 2.99856527 |
| 46 | Rhinitis (HP:0012384) | 2.98307136 |
| 47 | Palpitations (HP:0001962) | 2.93264341 |
| 48 | Ketoacidosis (HP:0001993) | 2.88936929 |
| 49 | Neck muscle weakness (HP:0000467) | 2.84208344 |
| 50 | Abnormal EKG (HP:0003115) | 2.83221744 |
| 51 | Hyperkalemia (HP:0002153) | 2.76109965 |
| 52 | Dilated cardiomyopathy (HP:0001644) | 2.69321422 |
| 53 | Obstructive sleep apnea (HP:0002870) | 2.64675499 |
| 54 | Fetal akinesia sequence (HP:0001989) | 2.61224772 |
| 55 | Difficulty climbing stairs (HP:0003551) | 2.58763307 |
| 56 | Rimmed vacuoles (HP:0003805) | 2.54016908 |
| 57 | Increased variability in muscle fiber diameter (HP:0003557) | 2.52181978 |
| 58 | Rhabdomyolysis (HP:0003201) | 2.47244776 |
| 59 | Type 1 muscle fiber predominance (HP:0003803) | 2.43794327 |
| 60 | Ketosis (HP:0001946) | 2.40425062 |
| 61 | Protrusio acetabuli (HP:0003179) | 2.38810428 |
| 62 | Myokymia (HP:0002411) | 2.33201870 |
| 63 | Hypoglycemic coma (HP:0001325) | 2.32461816 |
| 64 | Hamartoma of the eye (HP:0010568) | 2.30573017 |
| 65 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.24295612 |
| 66 | Abnormality of the foot musculature (HP:0001436) | 2.21534613 |
| 67 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.21149746 |
| 68 | Spinal rigidity (HP:0003306) | 2.18018005 |
| 69 | Foot dorsiflexor weakness (HP:0009027) | 2.16493828 |
| 70 | EMG: neuropathic changes (HP:0003445) | 2.15944793 |
| 71 | Muscle stiffness (HP:0003552) | 2.15153496 |
| 72 | Lymphangioma (HP:0100764) | 2.13234466 |
| 73 | Calcaneovalgus deformity (HP:0001848) | 2.12729655 |
| 74 | Hip contracture (HP:0003273) | 2.11725571 |
| 75 | Lower limb amyotrophy (HP:0007210) | 2.10916547 |
| 76 | Frequent falls (HP:0002359) | 2.10511885 |
| 77 | Limb-girdle muscle atrophy (HP:0003797) | 2.09016502 |
| 78 | Visual hallucinations (HP:0002367) | 2.07237675 |
| 79 | Abnormality of the nasal mucosa (HP:0000433) | 2.06300385 |
| 80 | Nasal polyposis (HP:0100582) | 2.05675272 |
| 81 | Action tremor (HP:0002345) | 2.04867161 |
| 82 | Chronic bronchitis (HP:0004469) | 2.04774798 |
| 83 | Broad metatarsal (HP:0001783) | 2.04666391 |
| 84 | Impaired social interactions (HP:0000735) | 2.04574785 |
| 85 | Abnormal social behavior (HP:0012433) | 2.04574785 |
| 86 | Bulbar palsy (HP:0001283) | 2.01903328 |
| 87 | Distal lower limb amyotrophy (HP:0008944) | 1.98262676 |
| 88 | Generalized muscle weakness (HP:0003324) | 1.98034937 |
| 89 | Focal motor seizures (HP:0011153) | 1.95527887 |
| 90 | Rapidly progressive (HP:0003678) | 1.93015122 |
| 91 | Bronchiectasis (HP:0002110) | 1.92886934 |
| 92 | Sudden cardiac death (HP:0001645) | 1.92561977 |
| 93 | Abnormality of the lower motor neuron (HP:0002366) | 1.91773347 |
| 94 | Central scotoma (HP:0000603) | 1.91080040 |
| 95 | Facial diplegia (HP:0001349) | 1.90998771 |
| 96 | Gowers sign (HP:0003391) | 1.89618021 |
| 97 | Left ventricular hypertrophy (HP:0001712) | 1.88257913 |
| 98 | Focal seizures (HP:0007359) | 1.87018694 |
| 99 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.86728377 |
| 100 | Arterial tortuosity (HP:0005116) | 1.86191046 |
| 101 | Pheochromocytoma (HP:0002666) | 1.84336889 |
| 102 | Flat acetabular roof (HP:0003180) | 1.83226233 |
| 103 | Cerebral aneurysm (HP:0004944) | 1.82251722 |
| 104 | Conjunctival hamartoma (HP:0100780) | 1.82203018 |
| 105 | Atelectasis (HP:0100750) | 1.82183622 |
| 106 | Limited hip movement (HP:0008800) | 1.81907442 |
| 107 | Postural instability (HP:0002172) | 1.80979589 |
| 108 | Proximal amyotrophy (HP:0007126) | 1.80880825 |
| 109 | Vascular tortuosity (HP:0004948) | 1.80469886 |
| 110 | Deformed tarsal bones (HP:0008119) | 1.78859163 |
| 111 | Hypoplastic ischia (HP:0003175) | 1.78130102 |
| 112 | Testicular atrophy (HP:0000029) | 1.77678727 |
| 113 | Hemiplegia (HP:0002301) | 1.77597526 |
| 114 | Hyperammonemia (HP:0001987) | 1.77356987 |
| 115 | Hypoalphalipoproteinemia (HP:0003233) | 1.74858170 |
| 116 | Muscle fiber inclusion bodies (HP:0100299) | 1.74230600 |
| 117 | Aneurysm (HP:0002617) | 1.73761365 |
| 118 | Dysdiadochokinesis (HP:0002075) | 1.72898001 |
| 119 | Hyperglycinuria (HP:0003108) | 1.72826779 |
| 120 | Hyperactive renin-angiotensin system (HP:0000841) | 1.72528227 |
| 121 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.72502205 |
| 122 | Gout (HP:0001997) | 1.71363087 |
| 123 | Malignant hyperthermia (HP:0002047) | 1.71097399 |
| 124 | Aortic aneurysm (HP:0004942) | 1.71062628 |
| 125 | Genetic anticipation (HP:0003743) | 1.70840908 |
| 126 | Skin nodule (HP:0200036) | 1.70444744 |
| 127 | Poor eye contact (HP:0000817) | 1.70031025 |
| 128 | Infertility (HP:0000789) | 1.69511591 |
| 129 | Abnormality of the Achilles tendon (HP:0005109) | 1.69155922 |
| 130 | Athetosis (HP:0002305) | 1.68969980 |
| 131 | Upper limb amyotrophy (HP:0009129) | 1.68946867 |
| 132 | Achilles tendon contracture (HP:0001771) | 1.68758401 |
| 133 | Scapular winging (HP:0003691) | 1.66546731 |
| 134 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.65086660 |
| 135 | Polycythemia (HP:0001901) | 1.65015430 |
| 136 | Hyperglycemia (HP:0003074) | 1.64405581 |
| 137 | Deep venous thrombosis (HP:0002625) | 1.62834102 |
| 138 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.62357209 |
| 139 | Distal lower limb muscle weakness (HP:0009053) | 1.62212435 |
| 140 | Depression (HP:0000716) | 1.61610549 |
| 141 | Palmoplantar keratoderma (HP:0000982) | 1.61406270 |
| 142 | Nonprogressive disorder (HP:0003680) | 1.60621341 |
| 143 | Abnormality of the ischium (HP:0003174) | 1.60513209 |
| 144 | Distal upper limb amyotrophy (HP:0007149) | 1.59671065 |
| 145 | Absent phalangeal crease (HP:0006109) | 1.59280631 |
| 146 | Waddling gait (HP:0002515) | 1.57197264 |
| 147 | Neurofibrillary tangles (HP:0002185) | 1.51630696 |
| 148 | Hypercortisolism (HP:0001578) | 1.50863842 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.51958932 |
| 2 | LMTK2 | 3.34856600 |
| 3 | TTN | 3.16749373 |
| 4 | PHKG2 | 2.94642313 |
| 5 | PHKG1 | 2.94642313 |
| 6 | PKN2 | 2.65826023 |
| 7 | MAPK15 | 2.48428564 |
| 8 | DMPK | 2.23499274 |
| 9 | RIPK1 | 2.19765325 |
| 10 | MAP3K9 | 2.07766159 |
| 11 | PRKD3 | 1.84906555 |
| 12 | PRPF4B | 1.74347071 |
| 13 | OBSCN | 1.72571936 |
| 14 | PDK4 | 1.70954958 |
| 15 | PDK3 | 1.70954958 |
| 16 | KSR2 | 1.69629966 |
| 17 | MAP3K7 | 1.63052604 |
| 18 | SIK1 | 1.57040232 |
| 19 | NTRK3 | 1.56061826 |
| 20 | PAK6 | 1.55255876 |
| 21 | STK38 | 1.53829381 |
| 22 | TRPM7 | 1.52943901 |
| 23 | EPHA4 | 1.50930554 |
| 24 | MAP3K4 | 1.50014154 |
| 25 | NEK1 | 1.49913824 |
| 26 | TAOK1 | 1.49285331 |
| 27 | CAMK1G | 1.42297978 |
| 28 | DAPK2 | 1.42236626 |
| 29 | MYLK | 1.31383067 |
| 30 | CDK12 | 1.30077929 |
| 31 | PAK3 | 1.23065210 |
| 32 | MAP2K4 | 1.22973070 |
| 33 | CAMK1D | 1.21839290 |
| 34 | CAMKK1 | 1.21691894 |
| 35 | PDGFRA | 1.20760235 |
| 36 | PINK1 | 1.19019377 |
| 37 | MAP3K10 | 1.10256514 |
| 38 | RET | 1.06622518 |
| 39 | CDC42BPA | 1.05834004 |
| 40 | ICK | 1.03690835 |
| 41 | PTK6 | 1.02395673 |
| 42 | SGK3 | 1.00317650 |
| 43 | BCKDK | 1.00042680 |
| 44 | ERN1 | 0.99215759 |
| 45 | SIK2 | 0.98740578 |
| 46 | MARK1 | 0.98133144 |
| 47 | NEK9 | 0.97575076 |
| 48 | LATS2 | 0.97427353 |
| 49 | DYRK1B | 0.97375105 |
| 50 | PRKD1 | 0.96785971 |
| 51 | PIK3CG | 0.96538036 |
| 52 | PRKCH | 0.96481950 |
| 53 | EPHA2 | 0.96472113 |
| 54 | PRKAA1 | 0.95901821 |
| 55 | MINK1 | 0.94695101 |
| 56 | MAP3K6 | 0.93269392 |
| 57 | INSRR | 0.93020924 |
| 58 | PIK3CA | 0.92621272 |
| 59 | TYRO3 | 0.92067203 |
| 60 | EEF2K | 0.91169787 |
| 61 | MAPK7 | 0.90930989 |
| 62 | EPHA3 | 0.90252524 |
| 63 | NTRK2 | 0.85707140 |
| 64 | NTRK1 | 0.85662363 |
| 65 | MAP3K2 | 0.85063825 |
| 66 | PRKAA2 | 0.84913670 |
| 67 | MAPK12 | 0.83252825 |
| 68 | EPHB2 | 0.82030403 |
| 69 | FGFR4 | 0.81149862 |
| 70 | PDPK1 | 0.79847940 |
| 71 | CAMK1 | 0.77399127 |
| 72 | CAMK4 | 0.77083121 |
| 73 | PDK2 | 0.76361044 |
| 74 | FER | 0.74233978 |
| 75 | STK11 | 0.73702834 |
| 76 | LATS1 | 0.72928383 |
| 77 | MAP3K1 | 0.72372320 |
| 78 | PDK1 | 0.71692563 |
| 79 | MET | 0.71322514 |
| 80 | ARAF | 0.70007536 |
| 81 | KSR1 | 0.69928013 |
| 82 | MARK2 | 0.69659798 |
| 83 | WNK1 | 0.68901638 |
| 84 | ROCK1 | 0.67974790 |
| 85 | MST1R | 0.67973649 |
| 86 | CDK5 | 0.66900884 |
| 87 | EPHB1 | 0.66396085 |
| 88 | STK24 | 0.64427877 |
| 89 | AKT3 | 0.64168760 |
| 90 | ALK | 0.63234512 |
| 91 | PNCK | 0.62716316 |
| 92 | MAP2K3 | 0.61705902 |
| 93 | FGFR3 | 0.61176606 |
| 94 | JAK1 | 0.58571007 |
| 95 | PTK2B | 0.57374548 |
| 96 | SGK2 | 0.56678525 |
| 97 | TIE1 | 0.55720909 |
| 98 | MTOR | 0.54037188 |
| 99 | MAPK10 | 0.53895184 |
| 100 | SGK1 | 0.53345042 |
| 101 | UHMK1 | 0.53130653 |
| 102 | MOS | 0.52488907 |
| 103 | CAMK2D | 0.52408024 |
| 104 | TGFBR2 | 0.51933303 |
| 105 | ROCK2 | 0.51605641 |
| 106 | WNK4 | 0.50959796 |
| 107 | CAMK2A | 0.50690022 |
| 108 | MAPK4 | 0.50201215 |
| 109 | PRKD2 | 0.49061783 |
| 110 | MAP2K1 | 0.47798410 |
| 111 | PDGFRB | 0.47488672 |
| 112 | CAMK2G | 0.47306408 |
| 113 | PRKG1 | 0.46966515 |
| 114 | RPS6KA3 | 0.45929601 |
| 115 | MAP3K5 | 0.45810281 |
| 116 | MAP3K13 | 0.45623783 |
| 117 | NEK6 | 0.45441167 |
| 118 | PRKACG | 0.44905101 |
| 119 | RPS6KA2 | 0.44820655 |
| 120 | RPS6KC1 | 0.44026112 |
| 121 | RPS6KL1 | 0.44026112 |
| 122 | MAPKAPK3 | 0.43759133 |
| 123 | DDR2 | 0.43741479 |
| 124 | JAK2 | 0.42490612 |
| 125 | FGFR2 | 0.42314922 |
| 126 | MUSK | 0.40354629 |
| 127 | SGK223 | 0.40165126 |
| 128 | SGK494 | 0.40165126 |
| 129 | PTK2 | 0.40066222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.89698346 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.64220782 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.50403741 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.43319641 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.06549584 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.93032720 |
| 7 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.78957796 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.78536882 |
| 9 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.71073413 |
| 10 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.67764635 |
| 11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.60823686 |
| 12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.58233914 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.55659966 |
| 14 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.46855136 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.43773153 |
| 16 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.42772319 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.39631916 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.35900930 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.35099925 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.33726152 |
| 21 | Insulin secretion_Homo sapiens_hsa04911 | 1.30722292 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.27411804 |
| 23 | Circadian entrainment_Homo sapiens_hsa04713 | 1.24534949 |
| 24 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.24275256 |
| 25 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.22404251 |
| 26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.20273229 |
| 27 | Insulin resistance_Homo sapiens_hsa04931 | 1.19334952 |
| 28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.17637535 |
| 29 | Salivary secretion_Homo sapiens_hsa04970 | 1.16773858 |
| 30 | Renin secretion_Homo sapiens_hsa04924 | 1.16362763 |
| 31 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.14988466 |
| 32 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.14625485 |
| 33 | Olfactory transduction_Homo sapiens_hsa04740 | 1.13946261 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.13704413 |
| 35 | Long-term potentiation_Homo sapiens_hsa04720 | 1.11523577 |
| 36 | Adherens junction_Homo sapiens_hsa04520 | 1.11204050 |
| 37 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.11136691 |
| 38 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.09012342 |
| 39 | Histidine metabolism_Homo sapiens_hsa00340 | 1.07565351 |
| 40 | Tight junction_Homo sapiens_hsa04530 | 1.06994175 |
| 41 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.06889931 |
| 42 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.05335828 |
| 43 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.04797390 |
| 44 | Lysine degradation_Homo sapiens_hsa00310 | 1.02678734 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.99602967 |
| 46 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.99530538 |
| 47 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.97378509 |
| 48 | GABAergic synapse_Homo sapiens_hsa04727 | 0.96881976 |
| 49 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.96566777 |
| 50 | Axon guidance_Homo sapiens_hsa04360 | 0.95720168 |
| 51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.95696219 |
| 52 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.95041206 |
| 53 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.93893689 |
| 54 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.92355100 |
| 55 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.90441512 |
| 56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.89582517 |
| 57 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.88809527 |
| 58 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.87547121 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.87039010 |
| 60 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.86865544 |
| 61 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.86420926 |
| 62 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.86090360 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85150336 |
| 64 | Morphine addiction_Homo sapiens_hsa05032 | 0.84821403 |
| 65 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.84682663 |
| 66 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.84554477 |
| 67 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.84385849 |
| 68 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.84094946 |
| 69 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.83898541 |
| 70 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.81201854 |
| 71 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.79666160 |
| 72 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.78419779 |
| 73 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.76377706 |
| 74 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.74769213 |
| 75 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72121854 |
| 76 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.71754838 |
| 77 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.71709977 |
| 78 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.70825067 |
| 79 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70737019 |
| 80 | Glioma_Homo sapiens_hsa05214 | 0.70080693 |
| 81 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.70007294 |
| 82 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.68524425 |
| 83 | Gap junction_Homo sapiens_hsa04540 | 0.67176642 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.66580766 |
| 85 | Nicotine addiction_Homo sapiens_hsa05033 | 0.66517475 |
| 86 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65956435 |
| 87 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.65807045 |
| 88 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65779507 |
| 89 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65301182 |
| 90 | Prion diseases_Homo sapiens_hsa05020 | 0.64547487 |
| 91 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.63514750 |
| 92 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.63285801 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63032128 |
| 94 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62867523 |
| 95 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60696393 |
| 96 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.60581297 |
| 97 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.60414553 |
| 98 | Cocaine addiction_Homo sapiens_hsa05030 | 0.60209592 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59820281 |
| 100 | Taste transduction_Homo sapiens_hsa04742 | 0.59786142 |
| 101 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.59728512 |
| 102 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.59222700 |
| 103 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58733176 |
| 104 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58620317 |
| 105 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.58364343 |
| 106 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56467813 |
| 107 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.56045537 |
| 108 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55625169 |
| 109 | Focal adhesion_Homo sapiens_hsa04510 | 0.55287054 |
| 110 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55224703 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53211158 |
| 112 | Circadian rhythm_Homo sapiens_hsa04710 | 0.52825100 |
| 113 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50496604 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49675133 |
| 115 | ABC transporters_Homo sapiens_hsa02010 | 0.48030707 |
| 116 | Melanogenesis_Homo sapiens_hsa04916 | 0.47239797 |
| 117 | Endometrial cancer_Homo sapiens_hsa05213 | 0.47159427 |
| 118 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.47004430 |
| 119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46383509 |
| 120 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45839755 |
| 121 | Platelet activation_Homo sapiens_hsa04611 | 0.45605670 |
| 122 | Other glycan degradation_Homo sapiens_hsa00511 | 0.45248408 |
| 123 | Amoebiasis_Homo sapiens_hsa05146 | 0.44610242 |
| 124 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.44110154 |
| 125 | Long-term depression_Homo sapiens_hsa04730 | 0.42916067 |
| 126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42858274 |
| 127 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42617934 |
| 128 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.42572935 |
| 129 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41328757 |

